Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
We report here porphodilactol derivatives and their corresponding metal complexes. These systems show promise as "all-in-one" phototheranostics and are predicated on a design strategy that involves controlling the relationship between intersystem crossing (ISC) and photothermal conversion efficiency following photoexcitation. The requisite balance was achieved by tuning the aromaticity of these porphyrinoid derivatives and forming complexes with one of two lanthanide cations, namely Gd and Lu. The net result led to a metalloporphodilactol system, Gd--, with seemingly optimal ISC efficiency, photothermal conversion efficiency and fluorescence properties, as well as good chemical stability. Encapsulation of Gd-- within mesoporous silica nanoparticles (MSN) allowed its evaluation for tumour diagnosis and therapy. It was found to be effective as an "all-in-one" phototheranostic that allowed for NIR fluorescence/photoacoustic dual-modal imaging while providing an excellent combined PTT/PDT therapeutic efficacy and in 4T1-tumour-bearing mice.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163340 | PMC |
| http://dx.doi.org/10.1039/d0sc03368e | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fluorescence and photothermal dual-modal image guided integrated diagnosis and treatment.
Colloids Surf B Biointerfaces
October 2025
Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China. Electronic address:
The early diagnosis and real-time monitoring of cancer are great significance for the establishment of integrated diagnosis and treatment systems. In this study, organic molecules as an all-in-one phototheranostic named FL-DPP nanoparticles was developed for monitoring the location and size of tumour and for achieving photo and gene synergistic therapy. The photothermal conversion efficiency (η) of FL-DPP nanoparticles reached 29.
View Article and Find Full Text PDFDonor modulation brings all-in-one phototheranostics for NIR-II imaging-guided type-I photodynamic/photothermal synergistic cancer therapy.
Chem Sci
March 2025
Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province, Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education, School of Chemistry and Chemical Engineering, Shaanxi Normal University Xi'an Shaanxi Province 710119 P. R. China
Type-I photodynamic (PDT) and photothermal (PTT) synergistic therapy guided by fluorescence imaging in the near-infrared region II (NIR-II) is crucial for cancer diagnosis and treatment. Phototheranostics provide a promising system for efficient imaging-guided phototherapy, combining diagnostics with therapeutics within a single photosensitizer and avoiding the complexity of composition and low reproducibility of combination methods. Herein, we design and synthesize an all-in-one phototheranostic agent OTAB by modifying aza-BODIPY with a methoxy group substituted triphenylamine moiety, followed by the formation of nanoparticle OTAB@cRGD NPs self-assembly with DSPE-PEG-cRGD.
View Article and Find Full Text PDFMulti-Functional AIE Phototheranostic Agent Enhancing αPD-L1 Response for Oral Squamous Cell Carcinoma Immunotherapy.
Small
November 2024
School of Science and Engineering, Shenzhen Institute of Aggregate Science and Technology, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, China.
Article Synopsis
- - Oral squamous cell carcinoma (OSCC) is a common cancer in the head and neck region, with surgery being the main treatment, but new immunotherapy options like immune checkpoint blockade (ICB) targeting PD-1/PD-L1 face challenges due to a suppressive tumor environment and low PD-L1 levels.
- - Researchers developed "all-in-one" phototherapeutic nanoparticles (TSD NPs) that utilize reactive oxygen species and photothermal effects to enhance both photoimmunotherapy and ICB for treating OSCC.
- - The nanoparticles not only generate strong reactive oxygen species to induce immune cell activation but also increase PD-L1 expression on OSCC cells, making the combined treatment more effective without harming normal tissues
NIR-II Emissive Superoxide Radical Photogenerator for Photothermal/Photodynamic Therapy against Hypoxic Tumor.
Adv Healthc Mater
August 2024
Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515, P. R. China.
Due to the "Achilles' heels" of hypoxia, complicated location in solid tumor, small molecular photosensitizers with second near-infrared window (NIR-II) fluorescence, type-I photodynamic therapy (PDT), and photothermal therapy (PTT) have attracted great attention. However, these photosensitizers are still few but yet challenging. Herein, an "all in one" NIR-II acceptor-donor-acceptor fused-ring photosensitizer, Y6-Th, is presented for the in-depth diagnosis and efficient treatment of cancer.
View Article and Find Full Text PDFNickel(II) Phototheranostics: A Case Study in Photoactivated HO-Enhanced Immunotherapy.
J Am Chem Soc
October 2023
Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, P. R. China.
Phototheranostics have emerged as a promising subset of cancer theranostics owing to their potential to provide precise photoinduced diagnoses and therapeutic outcomes. However, the design of phototheranostics remains challenging due to the nature of tumors and their microenvironment, including limitations to the oxygen supply, high rates of recurrence and metastasis, and the immunosuppressive state of cancer cells. Here we report a dual-functional oxygen-independent phototheranostic agent, , rationally designed to provide a near-infrared (NIR) photoactivated thermal- and hydroxyl radical (•OH)-enhanced photoimmunotherapeutic anticancer response.
View Article and Find Full Text PDF